AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

387 hedge funds and large institutions have $7.52B invested in Amedisys in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 136 increasing their positions, 151 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

12% less capital invested

Capital invested by funds: $8.52B → $7.52B (-$996M)

15% less call options, than puts

Call options by funds: $33.9M | Put options by funds: $40M

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
387
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33.9M
Puts
$40M
Net Calls
Net Calls Change

Top Buyers

1 +$93.9M
2 +$69.7M
3 +$61.5M
4
RP
Riverbridge Partners
Minnesota
+$47.3M
5
BlackRock
BlackRock
New York
+$32M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$3.72M
127
$3.63M
128
$3.57M
129
$3.48M
130
$3.41M
131
$3.29M
132
$3.24M
133
$3.22M
134
$3.16M
135
$3.16M
136
$3.12M
137
$3.02M
138
$2.92M
139
$2.9M
140
$2.78M
141
$2.77M
142
$2.67M
143
$2.61M
144
$2.53M
145
$2.52M
146
$2.25M
147
$2.18M
148
$2.14M
149
$2.13M
150
$2.12M